This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Pellissier JM, Brisson M, Levin MJ.Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine 25: 8326-8337, No. 49, 28 Nov 2007
Rights and permissions
About this article
Cite this article
Live varicella zoster virus vaccine of value in older adults. Pharmacoecon. Outcomes News 543, 6 (2007). https://doi.org/10.2165/00151234-200705430-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705430-00014